Search results for: 'biologics particip analyst'
- Did you mean
- biologics particip analysi
- biologics particip analysis
- Related search terms
- biologics contract development amp manufacturing market forecast to 2022
- biologics contract and development manufacturing
- Biologics Contract Development and Manufacturing
- biologics contracnt development and manufacturing
- biologics contract development ad manufacturing organizations
-
10 Sep 2024  |  Global  |  Technology Research
Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing
Increasing demand for small molecule drugs is driving the growth of modular and automated technologies in pharmaceutical manufacturing
This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized...
$4,950.00
Special Price $4,207.50 save 15 %
-
26 Aug 2024  |  Global  |  Market Research
Precision Neurodegenerative Disease Market, Global, 2024 2028
Precision NDD Treatment is Experiencing Transformational Growth due to AI Capabilities, Disease-modifying Therapies, and Industry Convergence
The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...
$2,450.00
Special Price $2,082.50 save 15 %
-
09 Sep 2024  |  Global  |  Technology Research
AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029
AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.
This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...
$4,950.00
Special Price $4,207.50 save 15 %
-
01 Mar 2024  |  North America  |  Market Research
Global Orphan Drug Growth Opportunities
Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions
In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...
$4,950.00
Special Price $3,712.50 save 25 %